These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9123108)

  • 1. Biological immunosuppressants: the way to clinical transplantation tolerance.
    Chatenoud L
    Transplant Proc; 1997; 29(1-2):51-5. PubMed ID: 9123108
    [No Abstract]   [Full Text] [Related]  

  • 2. Review and preview of anti-T-cell antibodies.
    Helderman JH
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):8-9. PubMed ID: 7482824
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological reagents for immunosuppressants.
    Soulillou JP
    Transplant Proc; 1995 Feb; 27(1):106-8. PubMed ID: 7878803
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical application of monoclonal antibody therapies in renal transplantation.
    Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD
    Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into therapy with monoclonal antibodies in allograft transplantation.
    Schena FP
    Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
    [No Abstract]   [Full Text] [Related]  

  • 6. New usage paradigms in antibody therapy: safety of the new agents.
    Pescovitz MD
    Transplant Proc; 1999; 31(1-2):1201-2. PubMed ID: 10083537
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction immunosuppression.
    Kirk AD
    Transplantation; 2006 Sep; 82(5):593-602. PubMed ID: 16969280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective immunosuppression with anti-T cell monoclonal antibodies.
    Chatenoud L; Bach JF
    Clin Nephrol; 1992; 38 Suppl 1():S53-60. PubMed ID: 1295709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody induction therapy in pancreas transplantation.
    Gruessner RW
    Transplant Proc; 1998 Jun; 30(4):1556-9. PubMed ID: 9636632
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppression and tolerance for clinical organ allografts.
    Monaco AP
    Curr Opin Immunol; 1989 Aug; 1(6):1174-7. PubMed ID: 2679755
    [No Abstract]   [Full Text] [Related]  

  • 11. No long-term benefit of low-dose OKT3 induction therapy in non to moderately immunized renal allograft recipients.
    Bemelman FJ; Yong S; Parlevliet KJ; Surachno S; Schellekens PT; ten Berge RJ
    Transplant Proc; 2002 Dec; 34(8):3165-7. PubMed ID: 12493407
    [No Abstract]   [Full Text] [Related]  

  • 12. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.
    Ciancio G; Carreno M; Mathew J; Ricordi C; Garcia R; Karatzas T; Fuller L; Cirocco R; Burke G; Webb M; Nery J; Tzakis A; Roth D; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):943-4. PubMed ID: 8623473
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of a negative conversion trial and subsequent living donor kidney transplant outcome in recipients with a positive lymphocyte crossmatch.
    Huh KH; Kim SI; Joo DJ; Ju MK; Chang HK; Kim HJ; Kim YS; Kim MS
    Nephron Clin Pract; 2009; 111(1):c49-54. PubMed ID: 19052470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies.
    Delmonico FL; Knowles RW; Colvin RB; Cavender DE; Kawai T; Bedle M; Stroka D; Preffer FI; Haug C; Cosimi AB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):784-5. PubMed ID: 8438479
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of intravenous immunoglobulin in organ transplantation for noninfectious indications.
    Yussim A; Klein T; Or H; Shaharabani E; Bar-Nathan N; Shmueli D; Lustig S; Sobolev V; Shapira Z
    Transplant Proc; 1997 Nov; 29(7):3058-9. PubMed ID: 9365666
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. The Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1997; 29(1-2):73-6. PubMed ID: 9123162
    [No Abstract]   [Full Text] [Related]  

  • 17. In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment.
    Caillat-Zucman S; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L
    Transplant Proc; 1990 Aug; 22(4):1782. PubMed ID: 2143860
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: are milder immunosuppressive regimens advisable?
    Pascual J; Crespo M; Mateos ML; Marcén R; Orofino L; Burgos FJ; Liaño F; Ortuño J
    Transplant Proc; 1998 Jun; 30(4):1329-30. PubMed ID: 9636540
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with intestinal transplantation at the University of Miami.
    Tzakis A; Webb M; Nery J; Rogers A; Koutouby R; Ruiz P; Karatzas T; Thompson J; Ricordi C
    Transplant Proc; 1996 Oct; 28(5):2748-9. PubMed ID: 8908037
    [No Abstract]   [Full Text] [Related]  

  • 20. Annual review of transplantation.
    First MR
    Clin Transpl; 1990; ():357-73. PubMed ID: 2129410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.